These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group. Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318 [TBL] [Abstract][Full Text] [Related]
16. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. Mathew NT; Dexter J; Couch J; Flamenbaum W; Goldstein J; Rapoport A; Sheftell F; Saper J; Silberstein S; Solomon S Arch Neurol; 1992 Dec; 49(12):1271-6. PubMed ID: 1333181 [TBL] [Abstract][Full Text] [Related]
18. [Sumatriptan and its use in treatment of migraine and cluster headaches]. Prusiński A Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766 [TBL] [Abstract][Full Text] [Related]
19. Sumatriptan in the acute treatment of migraine. Tansey MJ; Pilgrim AJ; Lloyd K J Neurol Sci; 1993 Jan; 114(1):109-16. PubMed ID: 8381852 [TBL] [Abstract][Full Text] [Related]
20. Psychological status during migraine attack and interval before and after treatment with a selective 5-HT1-agonist. Göbel H; Krapat S Headache; 1993 Mar; 33(3):118-20. PubMed ID: 8387474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]